Quantcast
Home > Quotes > BASI
BASI

Bioanalytical Systems, Inc. Common Stock (BASI) Quote & Summary Data

$2
*  
0.02
0.99%
Get BASI Alerts
*Delayed - data as of May 23, 2019  -  Find a broker to begin trading BASI now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
View:    BASI After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
$ 1.40 / $ 3.80
1 Year Target
Today's High / Low
$ 2.03 / $ 1.98
Share Volume
499
50 Day Avg. Daily Volume
17,186
Previous Close
$ 2.02
52 Week High / Low
$ 2.59 / $ 1.18
Market Cap
20,581,062
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
-0.07

Intraday Chart

Shares Traded

Share Volume:
499
50 Day Avg. Daily Volume:
17,186

P/E Ratio

P/E Ratio:
NE
Forward P/E (1y):
Earnings Per Share (EPS):
$ -0.10

Trading Range

The current last sale of $2 is 69.49% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 2.03 $ 2.59
 Low: $ 1.98 $ 1.18

Company Description (as filed with the SEC)

Bioanalytical Systems, Inc. and its subsidiaries ("We," "Our," "us," the "Company," or "BASi") is a contract research organization ("CRO") that provides drug discovery and development services to the pharmaceutical industry, and sells analytical instruments to the pharmaceutical development and contract research industries. Our mission is to provide drug developers with superior scientific research and innovative analytical instrumentation in order to bring revolutionary new drugs to market quickly and safely. Our strategy is to provide services that will generate high-quality and timely data in support of new drug approval or use expansion. Our clients and partners include pharmaceutical, biotechnology, academic and government organizations.  ... More ...  

Nasdaq Official Price

Open Price:
$ 2.03
Open Date:
May 23, 2019
Close Price:
$ 2.02
Close Date:
May 22, 2019


Research Brokers before you trade

Want to trade FX?

Analyst Info